Bayer Woes Make a Monsanto Break Harder Not Easier
Bayer AG shareholders may be inured to the rising costs of litigation over the Roundup weedkiller the German company inherited with the 2018 takeover of GMO specialist Monsanto. But now a worry about Bayer’s other main business — pharmaceuticals — has........